BIODYNE HOLDING, S.A. sold 6.3% of their position (225.58K shares) of ENVVENO MEDICAL CORP on the open market
Open‑market sale worth $74.3K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 6/8/2020ACC: 0001493152-20-010731
10% Owner
Since May 2019
-225.58K
Net shares
Net seller
$74.3K
Total sold
3
Open market trades
0B · 3S
3
Total transactions
225.58K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−220K
Price / share
$0.33
Trade value
$72.60K
% of position
6.1%
6/2/2020
3.58M→3.36M
Common Stock
Direct
Shares
−3.90K
Price / share
$0.31
Trade value
$1.21K
% of position
0.1%
6/3/2020
3.36M→3.36M
Common Stock
Direct
Shares
−1.68K
Price / share
$0.31
Trade value
$521.73
% of position
0.1%
6/3/2020
3.36M→3.36M
Total
Net shares
−225.58K
Net value
-$74.33K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/2/2020 | S · Sale | −220K | $0.33 | $72.60K | 6.1% | 3.58M | 3.36M |
| Common Stock Direct | 6/3/2020 | S · Sale | −3.90K | $0.31 | $1.21K | 0.1% | 3.36M | 3.36M |
| Common Stock Direct | 6/3/2020 | S · Sale | −1.68K | $0.31 | $521.73 | 0.1% | 3.36M | 3.36M |
| Total | −225.58K | -$74.33K | ||||||
Derivative Transactions0
No derivative transactions reported